Skip to content
PICO Portalanswers from OpenAlex

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial

PaperCitations, authors & open-access status

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial have?

PICO Portalcitation count

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial has 49 citations in the OpenAlex counts PICO Portal stores.

When was Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial published?

PICO Portalyear

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial has 2024 year in the PICO Portal index.

What is the open-access status of Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial?

PICO Portaloa status

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial has hybrid oa status in the PICO Portal index.

What is the DOI of Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial?

PICO Portaldoi

The DOI for Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial is on the source record.

What is the PMID of Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial?

PICO Portalpmid

The PMID for Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial is on the source record.

What is the OpenAlex record for Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial?

PICO Portalopenalex

The OpenAlex for Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial